HW
ASTH icon

Hancock Whitney’s Astrana Health ASTH Stock Holding History

Hancock Whitney’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,104
Closed -$296K – 674
2024
Q3 		$296K Sell
5,104
-5
-0.1% -$246 0.01% 541
2024
Q2 		$207K Sell
5,109
-4,591
-47% -$182K 0.01% 584
2024
Q1 		$407K Sell
9,700
-193
-2% -$7.53K 0.01% 484
2023
Q4 		$379K Sell
9,893
-16
-0.2% -$533 0.01% 503
2023
Q3 		$306K Sell
9,909
-335
-3% -$11.6K 0.01% 526
2023
Q2 		$324K Sell
10,244
-4,738
-32% -$162K 0.01% 516
2023
Q1 		$546K Sell
14,982
-2,173
-13% -$76.1K 0.02% 414
2022
Q4 		$508K Sell
17,155
-3
-0% -$96 0.02% 428
2022
Q3 		$669K Sell
17,158
-262
-2% -$12K 0.03% 362
2022
Q2 		$672K Sell
17,420
-1,152
-6% -$43.8K 0.03% 362
2022
Q1 		$900K Sell
18,572
-2,491
-12% -$129K 0.03% 344
2021
Q4 		$1.55M Sell
21,063
-8,572
-29% -$704K 0.05% 280
2021
Q3 		$2.7M Buy
29,635
+310
+1% +$26.4K 0.09% 177
2021
Q2 		$1.84M Sell
29,325
-597
-2% -$22.1K 0.06% 297
2021
Q1 		$811K Buy
29,922
+1,084
+4% +$26.1K 0.03% 446
2020
Q4 		$527K Buy
+28,838
New +$518K 0.02% 514

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hancock Whitney's ASTH Position: Q4 2024 in Review

Hancock Whitney sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 5,104 shares — an estimated $296K sold.

Hancock Whitney first reported a position in ASTH in Q4 2020 and held it in 16 quarters. The position peaked at $2.7M in Q3 2021. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Hancock Whitney reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Hancock Whitney sold 5,104 Astrana Health shares in Q4 2024, an estimated $296K.
  • Hancock Whitney first reported a position in Astrana Health in Q4 2020 and held it in 16 quarters.
  • Hancock Whitney's Astrana Health position peaked at $2.7M in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Hancock Whitney's 13F filing for Q4 2024, filed 14 Feb 2025.